Arvinas Stock (NASDAQ: ARVN) stock price, news, charts, stock research, profile.
Open | $30.24 |
Close | $29.65 |
Volume / Avg. | 393.07K / 844.19K |
Day Range | 29.21 - 30.24 |
52 Wk Range | 13.57 - 53.08 |
Market Cap | $2.05B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 15.82% |
Days to Cover | 15.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arvinas (NASDAQ:ARVN) through any online brokerage.
Other companies in Arvinas’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
There is no analysis for Arvinas.
Arvinas has a consensus price target of $70.33.
The stock price for Arvinas (NASDAQ: ARVN) is $30.01 last updated July 26, 2024 at 7:48 PM EDT.
There are no upcoming dividends for Arvinas.
Arvinas’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Arvinas.
Arvinas is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.